Drug Shortage Report for OPTIRAY 320 (ULTRAJECT)

Last updated on 2020-02-05 History
Report ID 97485
Drug Identification Number 02035626
Brand name OPTIRAY 320 (ULTRAJECT)
Common or Proper name Ioversol Injection 68%
Company Name LIEBEL-FLARSHEIM COMPANY LLC
Market Status MARKETED
Active Ingredient(s) IOVERSOL
Strength(s) 68%
Dosage form(s) SOLUTION
Route of administration INTRAVASCULAR
Packaging size 125 ml
ATC code V08AB
ATC description X-RAY CONTRAST MEDIA, IODINATED
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-30
Estimated end date 2020-01-30
Actual end date 2020-01-17
Shortage status Resolved
Updated date 2020-02-05
Company comments For more information, please contact Methapharm Inc. at 1-800-287-7686, sales@methapharm.com.
Health Canada comments
Tier 3 Status No
Contact Address 8800 DURANT RD.
RALEIGH, NORTH CAROLINA
UNITED STATES 27616
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-02-05 French Compare
v5 2020-02-05 English Compare
v4 2019-10-31 English Compare
v3 2019-10-30 French Compare
v2 2019-10-30 English Compare
v1 2019-10-30 English Compare

Showing 1 to 6 of 6